Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $96.92M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.86M
Average 0.38M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +97.0% | +25.5% (3yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +97.0% over three years. Forward estimates point to Revenue at +25.5% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
InfuSystem Holdings, Inc. AMEX:INFU | $294.89M | $14.72 | Undervalued | 23.2 | +52.49% |
Profound Medical Corp. NASDAQ:PROF | $271.77M | $7.42 | Not rated | -6.3 | +12.07% |
Electromed, Inc. AMEX:ELMD | $198.79M | $24.32 | Undervalued | 30.5 | -7.33% |
TriSalus Life Sciences, Inc. NASDAQ:TLSI | $149.93M | $2.43 | Not rated | -7.4 | -56.15% |
Inogen, Inc. NASDAQ:INGN | $147.95M | $5.69 | Not rated | -7.0 | -17.75% |
Quanterix Corporation NASDAQ:QTRX | $139.11M | $2.93 | Not rated | -1.5 | -65.65% |
Perspective Therapeutics, Inc. AMEX:CATX | $113.89M | $0.94 | Not rated | -0.0 | -63.02% |
Outset Medical, Inc. NASDAQ:OM | $70.32M | $3.73 | Not rated | -1.2 | -34.46% |
Nano-X Imaging Ltd. NASDAQ:NNOX | $25.36M | $0.32 | Not rated | -1.5 | -78.79% |
SANUWAVE Health, Inc. NASDAQ:SNWV | $15.66M | $1.82 | Undervalued | 5.0 | -81.50% |
Continue the stock analysis
Jump to another research area for this company.